Our 2023 ESG Report represents our third standalone ESG disclosure publication, a process that began with our inaugural ESG Report published in 2021. In 2022, we supplemented our original ESG report by disclosing updates to key ESG datapoints and metrics.

For our 2023 ESG Report, we reassessed ESG topics relevant to our business activities with the aim of aligning our disclosures with ESG information we believe is most useful to investors and other stakeholders. Our ESG disclosures are structured around industry-specific issues for the Medical Equipment and Supplies industry, as defined by the Sustainability Accounting Standards Board (SASB), and was informed by other ESG reporting frameworks such as the Global Reporting Initiative and the World Economic Forum International Business Council’s Stakeholder Capitalism Metrics. Our strategic approach to ESG was further supported by benchmarking companies within our industry as well as third-party rating and ranking methodologies.

“At Outset, our ESG journey is rooted in our mission to catalyze permanent and profound change in where, when, and how dialysis is delivered to lower costs and restore identity, agency, and self-worth to patients.”
- Leslie Trigg, President and Chief Executive Officer.